Torthaí cuardaigh - Silke Duerr‐Stoerzer
- 1 - 2 toradh as 2 á dtaispeáint
-
1
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown H... de réir Tanja Fehm, Sven Becker, Silke Duerr‐Stoerzer, Karl Sotlar, Volkmar Mueller, D. Wallwiener, Nancy Lane, Erich Solomayer, Jonathan W. Uhr
Foilsithe / Cruthaithe 2007Artigo -
2
Inhibition of effector B cells by ibrutinib in systemic sclerosis de réir Jakob Einhaus, Ann‐Christin Pecher, Elisa Asteriti, Hannes Schmid, Kathy-Ann Secker, Silke Duerr‐Stoerzer, Hildegard Keppeler, Reinhild Klein, Corina Schneidawind, Jörg Henes, Dominik Schneidawind
Foilsithe / Cruthaithe 2020Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Internal medicine
Medicine
Antibody
B cell
Breast cancer
Breast tumor
Bruton's tyrosine kinase
Cancer
Cancer research
Chronic lymphocytic leukemia
Circulating tumor cell
Cytokine
HER2 negative
Ibrutinib
Immune system
Immunology
Leukemia
Metastasis
Metastatic breast cancer
Oncology
Primary tumor
Receptor
Surgical oncology
Tyrosine kinase